SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 286.23 |
| Enterprise Value ($M) | 234.65 |
| Book Value ($M) | 243.92 |
| Book Value / Share | 3.46 |
| Price / Book | 1.17 |
| NCAV ($M) | 230.57 |
| NCAV / Share | 3.27 |
| Price / NCAV | 1.24 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.87 |
| Current Ratio | 11.87 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 264.35 |
| Assets | 277.69 |
| Liabilities | 33.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -207.99 |
| Net Income | -192.96 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -166.52 |
| Cash from Investing | 100.94 |
| Cash from Financing | 53.33 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Flynn James E | 5.03 | ||
| 13G | Cormorant Asset Management, LP | 5.21 | ||
| 13D/A | NSV Investments I, L.P. | 12.00 | 0.00 | |
| 13G | Point72 Asset Management, L.P. | 5.10 | ||
| 13G/A | Citadel Advisors Llc | 7.30 | ||
| 13G | Vanguard Group Inc | 6.34 | ||
| 13G | BlackRock Inc. | 6.50 | ||
| 13G | Tang Capital Partners Lp | 5.20 | ||
| 13G/A | Fmr Llc | 0.55 | -95.76 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 37,369 | 448,629 | 8.33 | |
| 67,740 | 586,706 | 11.55 | |
| 32,530 | 159,033 | 20.45 | |
| 45,621 | 153,583 | 29.70 | |
| 108,475 | 417,721 | 25.97 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VOR – Vor Biopharma Inc. | VRTX – Vertex Pharmaceuticals Incorporated |
| VTRS – Viatris Inc. | VYGR – Voyager Therapeutics, Inc. |
| XBIT – XBiotech Inc. |
Financial data and stock pages provided by
Fintel.io